Stanford Nature study shows peripheral immune cells comprise rising share of aged human brain microglia
Peripheral immune infiltration emerges as a normal, age-dependent feature of the human brain rather than an exception. The finding reframes neuroimmunology around bidirectional blood-brain immune exchange and opens routes to modulate dementia risk via systemic hematopoiesis or barrier-targeted interventions. Evidence rests on mutation lineage tracing in a modest number of postmortem brains; larger, prospective cohorts are required to confirm dose-response relationships with cognitive outcomes.
Belk, Jaiswal and Chang combined single-cell RNA sequencing and lineage-tracing of somatic mutations in postmortem brains with longitudinal blood data from thousands of donors. They documented that clones carrying clonal-hematopoiesis mutations appear inside the brain parenchyma and increase from negligible levels in middle age to 10-30 % of microglia in donors over 70. The same clones had previously been linked to lower Alzheimer incidence, suggesting peripheral immune influx is not merely leakage but a functionally relevant process.
Jaiswal: Within 48 months, at least two phase-2 trials of agents that alter blood-brain-barrier permeability or clonal hematopoiesis will report statistically significant slowing of CDR-SB decline in adults over 70.
Sources (3)
- [1]Primary Source(https://www.nature.com/articles/s41586-026-08245-3)
- [2]Supporting Source(https://www.nejm.org/doi/10.1056/NEJMoa2207181)
- [3]Supporting Source(https://www.cell.com/neuron/fulltext/S0896-6273(22)00412-8)